Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Abgenix reports positive preclinical results for ABX-IL-8

Sep. 15, 1999

Hair growth promoters developed at Shiseido

Sep. 13, 1999

Access initiates clinical trial of OraDisc for amlexanox delivery

Sep. 10, 1999

Fujisawa seeks approval for tacrolimus ointment in the U.S.

Sep. 10, 1999

Vitrix soon to enter expanded clinical development

Sep. 10, 1999

Licensing opportunity from NIH: thymosin beta4 as a wound-healing agent

Sep. 7, 1999

Genzyme Tissue Repair's TGF-beta2 sponge evaluated in phase II diabetic foot ulcers

Sep. 3, 1999

ACS news: new compounds from Merck & Co. potently and selectively inhibit 5alpha-reductase type 1

Sep. 1, 1999

AGN-194310, a high-affinity RAR antagonist for treating retinoid-induced toxicities

Sep. 1, 1999

Apligraf skin construct speeds healing of diabetic foot ulcers

Aug. 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...